{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-087955","form_type":"8-K","ticker":"RNTX","cik":"0001420565","company_name":"Rein Therapeutics, Inc.","filed_at":"2025-04-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.243857+00:00","generated_at":"2026-05-23T09:11:58.846256+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Rein Therapeutics raises ~$5.05M via warrant exercises, exchanges, and private placement","bullets":["Holders exercise 2023 and 2024 warrants for 902,929 shares at reduced price of $1.60 per share.","Holders of 2023 warrants exchange 1,939,000 shares for pre-funded warrants plus cash payment of ~$1.599/share.","Bios affiliate purchases pre-funded warrants for 312,695 shares at $1.599 per share in private placement.","Total gross proceeds expected to be approximately $5.05 million.","Pre-funded warrants are immediately exercisable at $0.001 per share, subject to beneficial ownership limit."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-087955","json":"https://secwatch.observer/filing/0001193125-25-087955.json","markdown":"https://secwatch.observer/filing/0001193125-25-087955.md","text":"https://secwatch.observer/filing/0001193125-25-087955.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525087955/0001193125-25-087955-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525087955/d934084d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T09:11:58.846256+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}